BDO Wealth Advisors’s Pacira BioSciences PCRX Stock Holding History

BDO Wealth Advisors’s Portfolio PCRX Stock Details PCRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-9	Closed	-$1K	–	978
2020 Q3	$1K	Buy	+9	New	+$523	﹤0.01%	804

Other funds holding PCRX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

SCM

Spyglass Capital Management San Francisco, California $1.41B AUM 7.96% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

BDO Wealth Advisors's PCRX Position: Q4 2020 in Review

BDO Wealth Advisors sold out of Pacira BioSciences (PCRX) in Q4 2020, closing a stake of 9 shares — an estimated $1K sold.

BDO Wealth Advisors first reported a position in PCRX in Q3 2020 and held it in 1 quarter. The position peaked at $1K in Q3 2020. 260 funds tracked by Wall St. Rank hold PCRX as of Q4 2020.

BDO Wealth Advisors reported no remaining Pacira BioSciences position as of Q4 2020 after selling out during the quarter.
BDO Wealth Advisors sold 9 Pacira BioSciences shares in Q4 2020, an estimated $1K.
BDO Wealth Advisors first reported a position in Pacira BioSciences in Q3 2020 and held it in 1 quarter.
BDO Wealth Advisors's Pacira BioSciences position peaked at $1K in Q3 2020.
260 funds tracked by Wall St. Rank held Pacira BioSciences as of Q4 2020.

Based on BDO Wealth Advisors's 13F filing for Q4 2020, filed 12 Feb 2021.